• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

AMD stock falls on cautious comments at Morgan Stanley

by October 22, 2024
written by October 22, 2024

Investing.com — Shares of Advanced Micro Devices (NASDAQ: NASDAQ:AMD) fell over 3% on Tuesday following cautious remarks from Morgan Stanley, highlighting concerns about the company’s AI supply chain strategy. 

Analysts said in a note that AMD appears to have reduced its CoWoS wafer bookings at Taiwan Semiconductor Manufacturing Company (TSMC) for 2025 due to uncertainty about MI325 demand.

“AMD seems to have trimmed some CoWoS wafer booking at TSMC for 2025 given uncertainty around MI325 demand,” Morgan Stanley stated. 

The move suggests that AMD is taking a conservative approach to managing potential fluctuations in demand for its AI processors. 

However, Morgan Stanley analysts added that Nvidia (NASDAQ:NVDA) quickly absorbed the vacated capacity at TSMC, underscoring Nvidia’s aggressive positioning in the AI market.

The bank’s note also provided insight into broader trends in the semiconductor industry, indicating that other companies are ramping up production. 

They said that Marvell (NASDAQ:MRVL), for example, tripled its CoWoS bookings for 2025 compared to 2024. Meanwhile, Intel’s Habana division has kept its wafer bookings at TSMC unchanged, signaling stability in its AI-related production.

The analysts’ cautious tone on AMD follows a period of heightened competition in the AI space, with Nvidia solidifying its leadership. 

The note also says that “WPG sales grew 25% Q/Q in 3Q vs. previous guidance of only up 5.5% Q/Q,” with the bank highlighting citing “increasing business coming from AMD CPU and ‘GPU.’”

AMD shares are up around 5.9% for the year to date.

 

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Breaking the Grass Ceiling: Pot firms rethink strategy as young women lead cannabis use
next post
European shares sag, SAP boosts tech stocks after forecast raise

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!








    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • UPS is ‘disposing of’ U.S.-bound packages over customs paperwork problems

      October 13, 2025
    • China outlines more controls on exports of rare earths and technology

      October 10, 2025
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

      October 7, 2025
    • YouTube to pay $24 million to settle Trump lawsuit

      October 1, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (652)
    • Stock (6,426)

    Latest News

    • UPS is ‘disposing of’ U.S.-bound packages over customs paperwork problems
    • China outlines more controls on exports of rare earths and technology

    Popular News

    • Dow forecasts weak Q4, sagging demand leads to review of some Europe assets
    • Trump 2.0 to be modest positive for BioPharma, BMO says, but watch FDA

    About The Significant deals

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy